Amikacin (injection)
آمیکاسین (تزریقی)
🦠 Antiinfectives For Systemic UseAminoglycoside
Market / country: 🇺🇸 USA
Amikin (US)
🧮 Dose calculator
Sepsis / serious hospital infection (refer) · Regimen source: FDA Amikacin inj. · Dosage and Administration
- • i.e. 7.5 mg/kg every 12 h or 5 mg/kg every 8 h; max 1.5 g/day. Monitor serum levels, renal, auditory and vestibular function. FDA Amikacin inj. · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to amikacin or other aminoglycosides. FDA Amikacin inj. · Contraindications
Warnings
- • Boxed warning: oto-, nephro- and neuromuscular toxicity; fetal harm in pregnancy. FDA Amikacin inj. · Boxed WarningFDA Amikacin inj. · Warnings
Formulations
- 250 mg/mL (500 mg/2 mL; 1 g/4 mL) vial — injection 🇺🇸 USA FDA Amikacin inj. · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Amikacin inj. · Pregnancy
“Teratogenic Effects (See WARNINGS section.)”
- 🤱 BreastfeedingDangerous / avoid
Label: breastfeeding not recommended, or choose between the drug and breastfeeding. FDA Amikacin inj. · Nursing Mothers
“Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from amikacin, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Amikacin inj. · Pediatric Use
“Aminoglycosides should be used with caution in premature and neonatal infants because of the renal immaturity of these patients and the resulting prolongation of serum half-life of these drugs.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA203323
- DailyMed (FDA label)FDA Amikacin inj.
- MedlinePlus (NIH)Amikacin InjectionAmikacin Oral Inhalation
- WHO ATC/DDDJ01GB06
- Darooyab (Iran)Amikacin
🇮🇷 Registered in Iran Darooyab · G-273/Amikacin
Dosage forms with Iranian generic codes, per Darooyab.
- 00053 · AMIKACIN SULFATE 100MG/2ML AMP · آمپول آمیکاسین سولفات ۱۰۰ میلیگرم / ۲ میلیلیتر
- 00054 · AMIKACIN SULFATE 500MG/2ML AMP · آمپول آمیکاسین سولفات ۵۰۰ میلیگرم / ۲ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Amikacin inj. · How SuppliedFDA Amikacin inj. · Dosage and AdministrationFDA Amikacin inj. · Pediatric UseFDA Amikacin inj. · ContraindicationsFDA Amikacin inj. · Boxed WarningFDA Amikacin inj. · WarningsFDA Amikacin inj. · SPL approval / marketing categoryFDA Amikacin inj. · PregnancyFDA Amikacin inj. · Nursing Mothers
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-273/Amikacin
- Clinical review⚠ Unverified